Down-regulation of hepatic lipase expression by elevation of cAMP in human hepatoma but not adrenocortical cells

Molecular and Cellular Endocrinology

Volumn 294, Issue 1-2, 2008, Pages 37-44

  van Deursen, Diederik ^a   Botma, Gert Jan ^a   Jansen, Hans ^a   Verhoeven, Adrie J M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Adrenocortical cells; C EBP ; Cyclic AMP; Hepatic lipase; Liver cells; Promoter activity; Transcriptional regulation

Indexed keywords

8 BROMO CYCLIC AMP; ALPHA 1 ANTITRYPSIN; CCAAT ENHANCER BINDING PROTEIN; LIVER TRIACYLGLYCEROL LIPASE; MESSENGER RNA;

ADRENAL CORTEX CELL; AMINO ACID SEQUENCE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADRENAL CORTEX; ANIMALS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CYCLIC AMP; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPASE; PROTEIN BIOSYNTHESIS; RATS; RESPONSE ELEMENTS; TRANSFECTION;

EID: 53549092571     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.07.004     Document Type: Article

References (53)

1. Baynes C., Henderson A.D., Anyaoku V., Richmond W., Hughes C.L., Johnston D.G., and Elkeles R.S. The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diab. Med. 8 (1991) 560-566
2. Baynes C., Henderson A.D., Richmond W., Johnston D.G., and Elkeles R.S. The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes. Eur. J. Clin. Invest. 22 (1992) 341-346
3. Botma G.J., Verhoeven A.J., and Jansen H. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor. Atherosclerosis 154 (2001) 625-632
4. Botma G.J., van Deursen D., Vieira D., van Hoek M., Jansen H., and Verhoeven A.J. Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression. Atherosclerosis 179 (2005) 61-67
5. Botma G.J., Heuveling M., Lamers J.M., Jansen H., and Verhoeven A.J. Cloning, expression, and promoter analysis of hepatic lipase derived from human hyperplastic adrenals: evidence for alternative mRNA splicing. Cell. Biochem. Biophys. 47 (2007) 149-158
6. Carmona M.C., Hondares E., Rodriguez de la Concepcion M.L., Rodriguez-Sureda V., Peinado-Onsurbe J., Poli V., Iglesias R., Villarroya F., and Giralt M. Defective thermoregulation, impaired lipid metabolism, but preserved adrenergic induction of gene expression in brown fat of mice lacking C/EBPbeta. Biochem. J. 389 (2005) 47-56
7. Carr M.C., Hokanson J.E., Deeb S.S., Purnell J.Q., Mitchell E.S., and Brunzell J.D. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2701-2707
8. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
9. Cominacini L., Garbin U., Davoli A., Campagnola M., De Santis A., Pasini C., Pastorino A.M., and Bosello O. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels. Ann. Nutr. Metab. 37 (1993) 175-184
10. Datta S., Luo C.C., Li W.H., VanTuinen P., Ledbetter D.H., Brown M.A., Chen S.H., Liu S.W., and Chan L. Human hepatic lipase. Cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization, and evolutionary relationships with lipoprotein lipase and pancreatic lipase. J. Biol. Chem. 263 (1988) 1107-1110
11. Despres J.P., Ferland M., Moorjani S., Nadeau A., Tremblay A., Lupien P.J., Theriault G., and Bouchard C. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis 9 (1989) 485-492
12. Galan X., Peinado-Onsurbe J., Robert M.Q., Soley M., Llobera M., and Ramirez I. Acute regulation of hepatic lipase secretion by rat hepatocytes. Biochem. Cell Biol. 80 (2002) 467-474
13. Groussin L., Massias J.F., Bertagna X., and Bertherat J. Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R. J. Clin. Endocrinol. Metab. 85 (2000) 345-354
14. Higuchi R., Krummel B., and Saiki R.K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16 (1988) 7351-7367
15. Hornbuckle L.A., Everett C.A., Martin C.C., Gustavson S.S., Svitek C.A., Oeser J.K., Neal D.W., Cherrington A.D., and O'Brien R.M. Selective stimulation of G-6-Pase catalytic subunit but not G-6-P transporter gene expression by glucagon in vivo and cAMP in situ. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E795-808
16. Isaacs A., Sayed-Tabatabaei F.A., Njajou O.T., Witteman J.C., and van Duijn C.M. The -514 C->T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. J. Clin. Endocrinol. Metab. 89 (2004) 3858-3863
17. Jansen H., and de Greef W.J. L-type lipase activity in ovaries of superovulated rats. Relation to cholesterol homeostasis. Mol. Cell. Endocrinol. 57 (1988) 7-15
18. Jansen H., Verhoeven A.J., Weeks L., Kastelein J.J., Halley D.J., van den Ouweland A., Jukema J.W., Seidell J.C., and Birkenhager J.C. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2837-2842
19. Jansen H., Verhoeven A.J., and Sijbrands E.J. Hepatic lipase: a pro- or anti-atherogenic protein?. J. Lipid Res. 43 (2002) 1352-1362
20. Jensen E., Hansson P., Floren C.H., Nilsson A., and Nilsson-Ehle P. Cell-density-dependent release of hepatic lipase from cultured rat hepatocytes. Horm. Metab. Res. 21 (1989) 4-7
21. Katzel L.I., Coon P.J., Busby M.J., Gottlieb S.O., Krauss R.M., and Goldberg A.P. Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler. Thromb. 12 (1992) 814-823
22. Kel A.E., Gossling E., Reuter I., Cheremushkin E., Kel-Margoulis O.V., and Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 31 (2003) 3576-3579
23. Klin M., Smogorzewski M., Ni Z., Zhang G., and Massry S.G. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J. Clin. Invest. 97 (1996) 2167-2173
24. Kost D.P., DeFrances M.C., Lee C.R., and Michalopoulos G.K. Patterns of alpha-1-adrenergic receptor expression in regenerating and neoplastic hepatic tissue. Pathobiology 60 (1992) 303-308
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
26. Lekstrom-Himes J., and Xanthopoulos K.G. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273 (1998) 28545-28548
27. Manchado C., Yubero P., Vinas O., Iglesias R., Villarroya F., Mampel T., and Giralt M. CCAAT/enhancer-binding proteins alpha and beta in brown adipose tissue: evidence for a tissue-specific pattern of expression during development. Biochem. J. 302 (1994) 695-700
28. Matys V., Fricke E., Geffers R., Gossling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., Kloos D.U., Land S., Lewicki-Potapov B., Michael H., Munch R., Reuter I., Rotert S., Saxel H., Scheer M., Thiele S., and Wingender E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31 (2003) 374-378
29. Mirel R.D., Morris H.P., and DiAugustine R.P. Membrane receptor function and the loss of glucagon-stimulated adenylate cyclase activity in hepatomas. Endocrinology 102 (1978) 1237-1246
30. Morgan N.G., Waynick L.E., and Exton J.H. Characterisation of the alpha 1-adrenergic control of hepatic cAMP in male rats. Eur. J. Pharmacol. 96 (1983) 1-10
31. Morita T., Sakata K., Kanagawa A., and Ueki H. Stimulatory release of hepatic lipase activity from cultured rat hepatocytes by sodium orthovanadate: rapid increase in cyclic adenosine monophosphate content. Biol. Pharm. Bull. 17 (1994) 577-580
32. Neve B.P., Verhoeven A.J., and Jansen H. Acute effects of adrenaline on hepatic lipase secretion by rat hepatocytes. Metabolism 46 (1997) 76-82
33. 2+ homoeostasis: thapsigargin and EGTA both mimic the effect of adrenaline. Biochem. J. 330 (1998) 701-706
34. Nie L., Wang J., Clark L.T., Tang A., Vega G.L., Grundy S.M., and Cohen J.C. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J. Lipid Res. 39 (1998) 1127-1130
35. 2+ mobilization and cAMP accumulation in isolated rat hepatocytes. Eur. J. Pharmacol. 246 (1993) 113-120
36. Peinado-Onsurbe J., Soler C., Galan X., Poveda B., Soley M., Llobera M., and Ramirez I. Involvement of catecholamines in the effect of fasting on hepatic endothelial lipase activity in the rat. Endocrinology 129 (1991) 2599-2606
37. Peinado-Onsurbe J., Julve J., Galan X., Llobera M., and Ramirez I. Effect of fasting on hepatic lipase activity in the liver of developing rats. Biol. Neonate 77 (2000) 131-138
38. Perret B., Mabile L., Martinez L., Terce F., Barbaras R., and Collet X. Hepatic lipase: structure/function relationship, synthesis, and regulation. J. Lipid Res. 43 (2002) 1163-1169
39. Pollare T., Vessby B., and Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler. Thromb. 11 (1991) 1192-1203
40. Rich B.E., and Steitz J.A. Human acidic ribosomal phosphoproteins P0, P1, and P2: analysis of cDNA clones, in vitro synthesis, and assembly. Mol. Cell Biol. 7 (1987) 4065-4074
41. Roesler W.J. What is a cAMP response unit?. Mol. Cell. Endocrinol. 162 (2000) 1-7
42. Rufibach L.E., Duncan S.A., Battle M., and Deeb S.S. Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter. J. Lipid Res. 47 (2006) 1463-1477
43. Sanae F., Kohei K., Nomura M., and Miyamoto K. Studies on responsiveness of hepatoma cells to catecholamines. VI. Characteristics of adrenoceptors and adenylate cyclase response in rat ascites hepatoma cells and human hepatoma cells. J. Pharmacobiodyn 15 (1992) 303-309
44. Schoonderwoerd K., Hulsmann W.C., and Jansen H. Regulation of liver lipase. II. Involvement of the alpha 1-receptor. Biochim. Biophys. Acta 795 (1984) 481-486
45. Schreiber E., Matthias P., Muller M.M., and Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17 (1989) 6419
46. Song K.H., and Chiang J.Y. Glucagon and cAMP inhibit cholesterol 7alpha-hydroxylase (CYP7A1) gene expression in human hepatocytes: discordant regulation of bile acid synthesis and gluconeogenesis. Hepatology 43 (2006) 117-125
47. Stam H., Schoonderwoerd K., Breeman W., and Hulsmann W.C. Effects of hormones, fasting and diabetes on triglyceride lipase activities in rat heart and liver. Horm. Metab. Res. 16 (1984) 293-297
48. van Deursen D., Botma G.J., Jansen H., and Verhoeven A.J. Comparative genomics and experimental promoter analysis reveal functional liver-specific elements in mammalian hepatic lipase genes. BMC Genomics 8 (2007) 99
49. Verhoeven A.J., and Jansen H. Secretion of rat hepatic lipase is blocked by inhibition of oligosaccharide processing at the stage of glucosidase I. J. Lipid Res. 31 (1990) 1883-1893
50. Verhoeven A.J., Carling D., and Jansen H. Hepatic lipase gene is transcribed in rat adrenals into a truncated mRNA. J. Lipid Res. 35 (1994) 966-975
51. Verhoeven A.J., Neve B.P., and Jansen H. Secretion and apparent activation of human hepatic lipase requires proper oligosaccharide processing in the endoplasmic reticulum. Biochem. J. 337 (1999) 133-140
52. Vieira-van Bruggen D., Kalkman I., van Gent T., van Tol A., and Jansen H. Induction of adrenal scavenger receptor BI and increased high density lipoprotein-cholesteryl ether uptake by in vivo inhibition of hepatic lipase. J. Biol. Chem. 273 (1998) 32038-32041
53. Wilson H.L., and Roesler W.J. CCAAT/enhancer binding proteins: do they possess intrinsic cAMP-inducible activity?. Mol. Cell. Endocrinol. 188 (2002) 15-20